A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control ; volume:4 ; number:1 ; day:7 ; month:10 ; year:2011 ; pages:1-7 ; date:12.2011
Parasites & vectors ; 4, Heft 1 (7.10.2011), 1-7, 12.2011
- Urheber
-
Zhou, Yi-biao
Zheng, Hui-min
Jiang, Qing-wu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-3305-4-194
- URN
-
urn:nbn:de:101:1-2021081920333708291995
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhou, Yi-biao
- Zheng, Hui-min
- Jiang, Qing-wu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Estimating the prevalence of schistosomiasis japonica in China: a serological approach
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Estimating the prevalence of schistosomiasis japonica in China: a serological approach
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Estimating the prevalence of schistosomiasis japonica in China: a serological approach
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
A novel fluorescence immunochromatographic assay strip for the diagnosis of schistosomiasis japonica
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation
Biltricide/Praziquantel (Bayer)